Ep0091 820 — Tallahassee, Florida

Ep0091 820 is a clinical research site located in Tallahassee, Florida, United States 32308.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Ep0091 820 has participated in 1 clinical trials.

Therapeutic areas: Drug-resistant Epilepsy, Focal-Onset Seizures.

Sponsors: UCB Biopharma S.P.R.L..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ep0091 820?

Ep0091 820 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ep0091 820 conducted?

Ep0091 820 has 1 clinical trials on record. Their work covers Drug-resistant Epilepsy, Focal-Onset Seizures.

Is Ep0091 820 accredited by Crixeo Health?

Ep0091 820 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ep0091 820?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.